Chopas James George 4

What Happened James Chopas, VP and Chief Accounting Officer of Apellis Pharmaceuticals (APLS), sold 2,064 shares on January 22, 2026. The shares were disposed at $21.77 per share for a total transaction value of $44,924. The Form 4 lists the transaction type as a sale (S).

Key Details

• Transaction date: 2026-01-22; sale price: $21.77; shares sold: 2,064; total proceeds: $44,924.
• Transaction reported on SEC Form 4 filed 2026-01-23 (timely filing).
• Shares owned after the transaction: not reported in this filing.
• Footnote: sale was to cover tax withholding on Restricted Stock Units released January 21, 2026 (F1).
• Transaction type: open market or private sale (disposition, code S).

Context The filing shows a sale to satisfy tax withholding tied to RSU vesting— a routine administrative transaction common after equity awards vest. Such sell-to-cover transactions are not necessarily indicative of the insider’s view on the company’s prospects; purchases generally carry more weight as signals of insider confidence.